Post-exposure prophylaxis of systemic anthrax in mice and treatment with fluoroquinolones

J Antimicrob Chemother. 2004 Jul;54(1):95-9. doi: 10.1093/jac/dkh276. Epub 2004 May 26.

Abstract

Objectives: To compare the fluoroquinolones gatifloxacin and moxifloxacin with ciprofloxacin for post-exposure prophylaxis of systemic anthrax in a BALB/c mouse model.

Methods: Treated mice and controls were inoculated subcutaneously with 5 x 10(4) spores/mouse of Bacillus anthracis Ames strain and observed for 37 days after challenge. Treated mice were given 100 mg/kg of antibiotic orally twice daily for 14 days, starting at various times post-challenge.

Results: Treatment starting 6 h post-challenge resulted in survival rates of 90%, 15% and 40% for gatifloxacin, moxifloxacin and ciprofloxacin, respectively. Treatment commencing 24 h post-challenge resulted in survival rates of 65%, 10% and 5%, respectively. Treatment starting more than 24 h after exposure had little effect on survival.

Conclusions: Gatifloxacin appeared to be more effective than moxifloxacin or ciprofloxacin, at similar doses, for early post-exposure treatment of murine systemic anthrax. However, these results might be due to differences in potency or pharmacokinetic properties.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anthrax / microbiology
  • Anthrax / prevention & control*
  • Anti-Infective Agents / pharmacokinetics
  • Anti-Infective Agents / therapeutic use*
  • Aza Compounds / pharmacokinetics
  • Aza Compounds / therapeutic use
  • Bacillus anthracis / drug effects
  • Ciprofloxacin / pharmacokinetics
  • Ciprofloxacin / therapeutic use
  • Female
  • Fluoroquinolones / pharmacokinetics
  • Fluoroquinolones / therapeutic use*
  • Gatifloxacin
  • Mice
  • Mice, Inbred BALB C
  • Microbial Sensitivity Tests
  • Moxifloxacin
  • Quinolines / pharmacokinetics
  • Quinolines / therapeutic use
  • Survival Analysis

Substances

  • Anti-Infective Agents
  • Aza Compounds
  • Fluoroquinolones
  • Quinolines
  • Ciprofloxacin
  • Gatifloxacin
  • Moxifloxacin